Oxford Global Conferences are proud to present the 8th Annual Next Generation Sequencing Congress, taking place on 10-11 November 2016 at the Novotel London West in London, UK.
This highly prestigious event provides a unique opportunity for over 450 senior level experts to network about the current landscape of the industry and to facilitate high level scientific discussions in order to help the market going forward.
The next generation sequencing market represents a rapidly moving area of research. The industry is characterised by continuous improvements and developments aimed at affordable costs, improved efficiency & accuracy. Advancements in NGS technologies and platforms, improved NGS data analysis techniques as well as novel bioinformatics tools all underpin the industry’s unquestionable potential. It has also been highlighted that the global next generation sequencing market will reach $27.8 billion by 2022.
On day one this year’s revamped programme will cover advances in next generation sequencing platforms and key therapeutic applications. Presentations will extend to such vital research areas as improvements in DNA, RNA & protein sequencing technologies, latest gene editing techniques in NGS as well as case studies from utilising NGS in medicine and therapeutics.
A separate stream will be devoted to hot topic areas in NGS data management and bioinformatics. Delegates will have the unique opportunity to join discussions about the developments in NGS analysis technologies, integrating ‘omic’ data sets and Big Data and cloud computing strategies in NGS.
On day two highly distinguished speakers will address NGS clinical applications and diagnostics. Such key topic areas will be covered as case studies of using next generation sequencing in the clinic, novel technologies and platforms to analyse NGS data and integrating data sets. NGS for precision & personalised medicine will also be covered.
This highly prestigious event provides a unique opportunity for over 450 senior level experts to network about the current landscape of the industry and to facilitate high level scientific discussions in order to help the market going forward.
The next generation sequencing market represents a rapidly moving area of research. The industry is characterised by continuous improvements and developments aimed at affordable costs, improved efficiency & accuracy. Advancements in NGS technologies and platforms, improved NGS data analysis techniques as well as novel bioinformatics tools all underpin the industry’s unquestionable potential. It has also been highlighted that the global next generation sequencing market will reach $27.8 billion by 2022.
On day one this year’s revamped programme will cover advances in next generation sequencing platforms and key therapeutic applications. Presentations will extend to such vital research areas as improvements in DNA, RNA & protein sequencing technologies, latest gene editing techniques in NGS as well as case studies from utilising NGS in medicine and therapeutics.
A separate stream will be devoted to hot topic areas in NGS data management and bioinformatics. Delegates will have the unique opportunity to join discussions about the developments in NGS analysis technologies, integrating ‘omic’ data sets and Big Data and cloud computing strategies in NGS.
On day two highly distinguished speakers will address NGS clinical applications and diagnostics. Such key topic areas will be covered as case studies of using next generation sequencing in the clinic, novel technologies and platforms to analyse NGS data and integrating data sets. NGS for precision & personalised medicine will also be covered.
